Keyword: CodeEvolver protein engineering platform technology

Accelerating the Benefits Achievable from Biocatalysis

02.10.2014 - Recently, Codexis has signed a platform technology license agreement with GlaxoSmithKline (GSK). Under the terms of the agreement, Codexis, a developer of biocatalysts for the...

News

Codexis Enters into Technology Collaboration with GSK

12.08.2014 - Codexis, a developer of biocatalysts for the pharmaceutical and fine chemical industries headquartered in Redwood City, Calif./USA, has signed a platform technology license...